← Back to headlines
Merck and Kelun Lung Cancer Drug Shows Superiority
A combination therapy for lung cancer developed by Merck and Kelun has demonstrated better results than Keytruda in a late-stage clinical trial.
22 May, 12:12 — 22 May, 12:12
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
5h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
8h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
16h ago